REZOLUTE, INC. Debt Instrument, Interest Rate, Increase (Decrease)
REZOLUTE, INC. (RZLT) reported Debt Instrument, Interest Rate, Increase (Decrease) of 12.00% for the 3-month period ending 2018-03-31, per its 10-Q filed 2019-05-10.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateIncreaseDecrease · last filed 2019-05-10
- REZOLUTE, INC. debt instrument, interest rate, increase (decrease) for the quarter ending 2018-03-31 was 12.00%.
| Period end | Debt Instrument, Interest Rate, Increase (Decrease) 3 month |
|---|---|
| 2018-03-31 | 12.00% 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |